Concerns on Rivaroxaban Use in Cirrhosis: Pharmacokinetic, Safety, and Bleeding Risk Considerations. Akca M, Ketenci YB, Demiroz H, Avcioglu U, et al. J Hepatol 2025 Sep 17:S0168-8278(25)02489-4. doi: 10.1016/j.jhep.2025.

Read + Share

Amedeo Smart

Independent Medical Education

Akca M, Ketenci YB, Demiroz H, Avcioglu U, et al. Concerns on Rivaroxaban Use in Cirrhosis: Pharmacokinetic, Safety, and Bleeding Risk Considerations. J Hepatol 2025 Sep 17:S0168-8278(25)02489-4. doi: 10.1016/j.jhep.2025.
PMID: 40972841